Tom Neyarapally

Tom Neyarapally, an expert in AI-driven drug discovery, shares insights on the groundbreaking role of AI in drug development. He discusses the importance of collaboration between pharmaceutical giants and startups to enhance personalized therapies. Neyarapally emphasizes overcoming data challenges for better patient experiences and the need for accessible datasets for effective AI applications. The conversation also covers economic hurdles in drug discovery and how innovative technologies could make medications more affordable.